ClinicaliQ Trial Snapshot
- Developing a Brief Intervention to Communicate Cardiovascular Risk to Patients Presenting to the Emergency Department With Chest Pain: a Co-Production Approach. Phase 2. — Recruiting • Non-phase study • Cardiology / Cardiovascular • NCT06903442.
- What is being tested: A brief intervention designed to communicate future cardiovascular risk to emergency department patients with chest pain who have not had an acute heart attack, using blood test results to stratify risk levels.
- Patient eligibility overview: Emergency department patients presenting with chest pain who have been ruled out for acute myocardial infarction but are identified as having elevated future cardiovascular risk through biomarker testing.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
Some patients who come to the emergency department with chest pain and have not had a heart attack, are at an increased risk of having a heart attack in the future. The investigators know this by taking a blood test (troponin) which looks at damage to the patient's heart. These patients are often sent home from hospital with no information about their risk of heart disease. A patient survey revealed that patients in the emergency department would like to receive more information about heart disease. In this study the investigators…
Eligibility Snapshot
- : * Patients who present to the Emergency Department with symptoms suggestive of acute coronary syndrome * A maximum high-sensitivity cardiac troponin I between 5 ng/L and the sex-specific 99th centile. * Resides in Scotland and has a CHI number * Adults aged 18 and over * No history of cardiovascular disease * At least 1 modifiable cardiovascular risk factor: current smoker, hypertension (140/90 mmHg), hypercholesterolaemia (>6.0 mmol/L), overweight and obesity (BMI >25), hyperglycaemia or diabetes mellitus. * Patients who are able to provide informed consent
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.